186 related articles for article (PubMed ID: 31258762)
1. Pathologic and prognostic impacts of
Kim HS; Kim JH; Jang HJ
J Cancer; 2019; 10(11):2560-2567. PubMed ID: 31258762
[TBL] [Abstract][Full Text] [Related]
2. Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis.
Kim HS; Kim JH; Jang HJ; Han B; Zang DY
J Cancer; 2019; 10(1):20-27. PubMed ID: 30662521
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.
Chang J; Liu X; Wang S; Zhang Z; Wu Z; Zhang X; Li J
PLoS One; 2014; 9(8):e105524. PubMed ID: 25171497
[TBL] [Abstract][Full Text] [Related]
4. High-level FGFR2 amplification is associated with poor prognosis and Lower response to chemotherapy in gastric cancers.
Hur JY; Chao J; Kim K; Kim ST; Kim KM; Klempner SJ; Lee J
Pathol Res Pract; 2020 Apr; 216(4):152878. PubMed ID: 32089408
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis.
Qiu Y; Zhang Z; Chen Y
Front Oncol; 2021; 11():537140. PubMed ID: 33777726
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis.
Cheng F; Zeng C; Zeng L; Chen Y
Medicine (Baltimore); 2019 Oct; 98(40):e17310. PubMed ID: 31577724
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and pathological impact of tumor budding in gastric cancer: A systematic review and meta-analysis.
Guo YX; Zhang ZZ; Zhao G; Zhao EH
World J Gastrointest Oncol; 2019 Oct; 11(10):898-908. PubMed ID: 31662828
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis.
Kim JH; Kim HS; Kim BJ
J Cancer; 2018; 9(10):1836-1845. PubMed ID: 29805710
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.
Seo S; Park SJ; Ryu MH; Park SR; Ryoo BY; Park YS; Na YS; Lee CW; Lee JK; Kang YK
Oncotarget; 2017 May; 8(20):33844-33854. PubMed ID: 27802183
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological value of the geriatric nutritional risk index in gastric cancer: A meta-analysis of 5,834 patients.
He L; Li Y; Qu L; Zhang F
Front Surg; 2022; 9():1087298. PubMed ID: 36684163
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of CD44 expression in gastric cancer: a meta-analysis.
Chen Y; Fu Z; Xu S; Xu Y; Xu P
Biomed Pharmacother; 2014 Jul; 68(6):693-7. PubMed ID: 25194445
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of high c-Met expression in ovarian cancer: a meta-analysis.
Kim JH; Jang HJ; Kim HS; Kim BJ; Park SH
J Cancer; 2018; 9(19):3427-3434. PubMed ID: 30310499
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis.
Ge H; Yan Y; Guo L; He X; Yang X
Clin Chim Acta; 2017 Nov; 474():114-119. PubMed ID: 28939099
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
Wu JX; Zhao YY; Wu X; An HX
PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
[TBL] [Abstract][Full Text] [Related]
15. Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance.
Shoji H; Yamada Y; Okita N; Takashima A; Honma Y; Iwasa S; Kato K; Hamaguchi T; Shimada Y
Anticancer Res; 2015 Sep; 35(9):5055-61. PubMed ID: 26254407
[TBL] [Abstract][Full Text] [Related]
16. Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis.
Ruan H; Hu S; Zhang H; Du G; Li X; Li X; Li X
Oncotarget; 2017 Dec; 8(68):113163-113173. PubMed ID: 29348895
[TBL] [Abstract][Full Text] [Related]
17. The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis.
Li Y; Huang Q; Zhou Y; He M; Chen J; Gao Y; Wang X
Front Pharmacol; 2018; 9():1494. PubMed ID: 30733677
[No Abstract] [Full Text] [Related]
18. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic Significance of
Kim HS; Kim JH; Jang HJ; Han B; Zang DY
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149673
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: A systemic review and meta-analysis.
Zheng LN; Wen F; Xu P; Zhang S
World J Clin Cases; 2019 Oct; 7(20):3247-3258. PubMed ID: 31667175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
